Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

This is the first time such results have been achieved in both children and adult patients born with a specific type of ...

Preclinical data support a novel combination of MB-101 (IL13Ra2-targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) to optimize clinical results FDA previously granted Orphan Drug ...

It is clear that a significant number of those elected to represent us in Congress have never experienced poverty or needed ...

Ladenburg Thalmann & Co, Inc. is acting as the exclusive placement agent for the offering.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...

A newer COVID-19 variant may be causing a severe sore throat in those who contract the infections. Here's what to know about "razor blade throat." ...